title: [Managing side effects of androgene deprivation in prostate cancer].
authors.affiliation: Urologische Klinik und Poliklinik der TU München, Klinikum rechts der Isar. mark.thalgott@lrz.tum.de
authors.forename: Mark
authors.initials: M
authors.lastname: Thalgott
authors.forename: Jürgen E
authors.initials: JE
authors.lastname: Gschwend
authors.forename: Margitta
authors.initials: M
authors.lastname: Retz
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy*; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013739:Testosterone